Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Irinotecan in High-Risk Resectable Metastatic Colorectal Cancer
NCT00003544Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 1998
- Primary completion
- Mar 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in metastatic colorectal cancer (mCRC), sponsored by Memorial Sloan Kettering Cancer Center. Started Jun 1998; status: completed.
02
Drugs
irinotecan
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00003544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003544.